X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Clinical Trials

N-Side Launches new innovative software for end-to-end Clinical Supply Chain Optimization

Content Team by Content Team
27th March 2019
in Clinical Trials, Manufacturing, News
N-Side Launches new innovative software for end-to-end Clinical Supply Chain Optimization

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

N-SIDE, a global software consulting company specializing in advanced analytics technologies, recently launched the N-SIDE Suite for Clinical Trials. The new product is the only one on the market that optimizes the entire clinical trial supply chain management process from planning and production through to protocol design and delivery of supplies. State-of-the-art data analytics and machine learning algorithms optimize decision-making and future-proof design & planning.

Managing clinical trials is becoming increasingly complex, with drug companies facing rising pressure to reduce drug waste and minimize costs while maintaining high levels of service for patients. It’s more important than ever that the uncertainty inherent in global trials can be managed in a safe and efficient way to ensure patients receive their medication on time.

The N-SIDE Suite for Clinical Trials provides an innovative solution to these problems, giving pharmaceutical and biotech companies the power to future-proof their clinical trials planning by using an intelligent blend of advanced analytics technologies to produce reliable forecasts. Simulations are run 1000s of times allowing for informed production planning and proactive risk mitigation, ultimately resulting in reduced drug waste.

Rather than stand-alone tools optimizing different components of clinical trials, N-SIDE offers a suite of ?integrated applications?? to globally optimize clinical trial supply chain management from start to finish.

The N-SIDE Production App optimizes strategic decisions to achieve the most efficient end-to-end production plan for each compound.

The N-SIDE Supply App optimizes clinical trial supply management from protocol design through to operation of ongoing trials.

The N-SIDE Dashboard App visualizes and allows interaction with data, providing feedback using current trial data and alerting users if studies deviate from the agreed uncertainty assumptions. It allows clinical supply chain teams to share latest status and relevant data with the whole organization, from management to finance.

The N-SIDE apps feed into a single, centralized database allowing information to be shared easily and efficiently between different stakeholders, increasing transparency and communication across the organization and allowing collaborative decision making.

N-SIDE has been an active player in clinical trial supply forecasting and simulation for more than 15 years. The N-SIDE Suite improves on the already successful CT-FAST which facilitates robust forecasting of the supply process. This new suite of applications will enable clinical trial managers in the pharmaceutical and biotech industry to future-proof their clinical trial supply chain management whilst minimizing costs, drug waste and risk.

 

Previous Post

Bemis Healthcare Packaging introduces Insura seal verification technology

Next Post

Cargolux seals partnership with Sonoco Thermosafe

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Cargolux seals partnership with Sonoco Thermosafe

Cargolux seals partnership with Sonoco Thermosafe

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In